Global Marketing Services is revolutionizing tuberculosis diagnosis by introducing the rapid and precise Cepheid Xpert MTB/RIF test, enabling timely detection and treatment to combat Pakistan’s high TB burden.

Tuberculosis (TB) remains a major public health challenge in Pakistan, with the country ranking fifth globally in terms of disease burden. Each year, an estimated 510,000–730,000 new cases emerge, underscoring the urgent need for early and precise detection. TB is a curable disease, but delays in diagnosis and treatment contribute to its continued spread. Rapid and accurate testing is essential not only for improving patient outcomes but also for preventing transmission within communities. At Global Marketing Services, Pakistan, we are here to transform the diagnostic landscape in Pakistan by introducing the Cepheid Xpert MTB/RIF test. This advanced solution provides fast and precise detection of Mycobacterium tuberculosis (MTB) and Rifampicin (RIF) resistance in less than two hours. With its simple three-step process and on-demand capability, it empowers physicians to make timely and informed decisions, significantly improving patient care. By bringing this innovation to Pakistan, we are strengthening the fight against TB, ensuring that diagnosis is not a barrier to treatment but a pathway to recovery.